Good news came from Unicorn that the company has recently obtained five national patents and relevant patent certificates issued by the China National Intellectual Property Administration.

Recently, the People's Government of Jinling Town, Zhaoyuan City successfully signed a contract with Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. to produce 40 billion plant capsules annually. Wang Xiaogang, a member of the Standing Committee and Vice Mayor of Zhaoyuan City, Yang Guang, Vice Chairman of the Zhaoyuan Municipal Political Consultative Conference and Director of the Commerce Bureau, Sheng Haixiang, Secretary of the Jinling Town Party Committee, Ren Zhumei, Mayor of Jinling Town Government, Song Yunqiang, General Manager of Dayou Shuoneng Industrial Co., Ltd., and Liu Naiyu, General Manager of Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. attended the signing ceremony.

On October 18th, the People's Government of Liangzhou District in Wuwei City successfully signed a contract with Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. for the 40 billion plant capsule project. Cui Zhenhua, Deputy Secretary of the Liangzhou District Committee and District Government Mayor of Wuwei City, attended the signing ceremony and delivered a speech, expressing full support for providing services around the project settlement. Liu Naiyu, Chairman of Dayou Unicorn, signed a cooperation agreement with the Liangzhou District People's Government of Wuwei City as the signing representative.

Precision medicine is a cutting-edge field in global biopharmaceutical technology, representing the development trend of future life sciences. Promoting the transformation of technological innovation achievements in this field is of great significance for China to achieve the strategy of becoming a technology powerhouse and a healthy China. As one of the key activities of the "2023 Shanghai Biomedical Industry Week", today (October 17), the "Gathering Moments to Seek Far Precision Jiasu" 2023 Jiading Precision Medicine Industry Development Conference and 2023 Precision Medicine Industrialization (Shanghai) Forum were successfully held in Jiading, Shanghai.

On September 20-22, the 2023 Asia International Nutrition and Health Food Exhibition&Asia Food Ingredients Exhibition was held in Bangkok, Thailand. Unicorn and leading nutritional and health industry leaders from around the world are participating in the exhibition, showcasing Unicorn capsule products and capsule solutions at booth D46. Together, we explore the development trends of plant-based pharmaceutical excipients and welcome new opportunities and challenges.

Good news came from Unicorn that the company has recently obtained five national patents and relevant patent certificates issued by the China National Intellectual Property Administration.

On August 4, 2023, Qin Weifeng and Shi Zhe from the Port Logistics Industrial Park of Taizhou Pharmaceutical High tech Zone (Gaogang District) visited our company for inspection and negotiation. Our General Manager Dai Weidong warmly received the visiting leaders and discussed the topic of "how to build the entire pharmaceutical industry chain".

On the morning of June 29, 2023, Xu Jun, chairman of Tengzhou Xinhua Investment Group, and other three people came to our company to visit and negotiate.

The plant capsule is a coat that wraps the drug, the purpose is to make the drug easier to take, to achieve the best effect.
In the practical application of plant capsules, pharmaceutical companies generally print logos on the surface of capsules, such as trademark letters, trademark names or drug names, in order to facilitate product identification, protect their own brands and prevent counterfeiting.